The upregulation of TOR1B was highly significant in patients with BM (p = 8e-04 and p = 4.5e-05, metastatic vs. nonmetastatic BC, E-MTAB-365 and GSE2034 datasets, respectively) (Fig. 2). This evidence concerns the gene TOR1B and breast cancer.